1. Repository of OAI
Ελληνικά   English  
Saved Searches

Discover

Search


Current filters:


Clear current filters  or Add more filters

View Option


Results 1-10 of 18 (Search time: 0.003 seconds).

  Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia (Journal article)

  Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative study (Journal article)

  Lipophilic statins do not affect the antiplatelet potency of clopidogrel (Journal article)

  Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment (Journal article)

  Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes - Role of the lipoprotein-associated phospholipase A(2) and the effect of atorvastatin treatment (Journal article)

  Acute and long-term antiplatelet therapy (Journal article)

  Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart disease (Journal article)

  Clinical significance of the atorvastatin-clopidogrel drug-drug interaction - Response (Journal article)

  Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes (Journal article)

  The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease (Journal article)